These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24344046)

  • 1. Dissociated evolution of a multifocal primary CNS lymphoma.
    Bagacean C; Zdrenghea M; Popescu C; Quintin-Roue I; Ianotto JC; Eveillard JR; Berthou C; Tempescul A
    J BUON; 2013; 18(4):1098. PubMed ID: 24344046
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose chemotherapy and autologous stem-cell transplantation without consolidating radiotherapy as first-line treatment for primary lymphoma of the central nervous system.
    Illerhaus G; Müller F; Feuerhake F; Schäfer AO; Ostertag C; Finke J
    Haematologica; 2008 Jan; 93(1):147-8. PubMed ID: 18166803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment approaches for primary CNS lymphomas.
    Carrabba MG; Reni M; Foppoli M; Chiara A; Franzin A; Politi LS; Villa E; Ciceri F; Ferreri AJ
    Expert Opin Pharmacother; 2010 Jun; 11(8):1263-76. PubMed ID: 20429667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary central nervous system lymphoma: diagnosis, management and current topics].
    Arita N
    No To Shinkei; 2004 Mar; 56(3):195-203. PubMed ID: 15112444
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma.
    Cheng T; Forsyth P; Chaudhry A; Morris D; Glück S; Russell JA; Stewart DA
    Bone Marrow Transplant; 2003 Apr; 31(8):679-85. PubMed ID: 12692608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary central nervous system lymphoma: recent progress, many remaining questions.
    Swinnen LJ
    Curr Opin Oncol; 2009 Sep; 21(5):393-6. PubMed ID: 19593137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination immunotherapy as a non-chemotherapy alternative for refractory or recurrent CNS lymphoma.
    Ambady P; Szidonya L; Firkins J; James J; Johansson K; White T; Jezierski C; Doolittle ND; Neuwelt EA
    Leuk Lymphoma; 2019 Feb; 60(2):515-518. PubMed ID: 30033836
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary central nervous system lymphoma.
    Stern JI; Raizer JJ
    Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S63-70. PubMed ID: 16274272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual uterine recurrence of primary central nervous system lymphoma.
    Nichols GL; Jacobson CA; Ferman D; Lichtman SM
    Clin Adv Hematol Oncol; 2006 Sep; 4(9):697-8, discussion 699-700. PubMed ID: 17099627
    [No Abstract]   [Full Text] [Related]  

  • 10. Hodgkin's lymphoma involving the CNS.
    Morawa E; Ragam A; Sirota R; Nabhan C
    J Clin Oncol; 2007 Apr; 25(11):1437-8. PubMed ID: 17416864
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose chemotherapy with autologous stem cell transplantation in adults with recurrent embryonal tumors of the central nervous system.
    Gill P; Litzow M; Buckner J; Arndt C; Moynihan T; Christianson T; Ansell S; Galanis E
    Cancer; 2008 Apr; 112(8):1805-11. PubMed ID: 18300237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
    Colombat P; Lemevel A; Bertrand P; Delwail V; Rachieru P; Brion A; Berthou C; Bay JO; Delepine R; Desablens B; Camilleri-Broët S; Linassier C; Lamy T
    Bone Marrow Transplant; 2006 Sep; 38(6):417-20. PubMed ID: 16951691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
    Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
    Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic management of primary CNS lymphoma in immunocompetent patients.
    Reni M; Ferreri AJ
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):382-94. PubMed ID: 12113105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual variants of primary central nervous system lymphoma.
    Shenkier TN
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):651-64, vi. PubMed ID: 16083828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system lymphoma.
    Gallop-Evans E
    Clin Oncol (R Coll Radiol); 2012 Jun; 24(5):329-38. PubMed ID: 22459053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic implication of p27 expression in primary central nervous system lymphoma.
    Kunishio K; Nagao S
    Brain Tumor Pathol; 2006 Oct; 23(2):77-81. PubMed ID: 18095123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line autologous stem cell transplantation in primary CNS lymphoma.
    Brevet M; Garidi R; Gruson B; Royer B; Vaida I; Damaj G
    Eur J Haematol; 2005 Oct; 75(4):288-92. PubMed ID: 16146534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable outcome of primary CNS anaplastic large cell lymphoma in an immunocompetent patient.
    Ozkaynak MF
    J Pediatr Hematol Oncol; 2009 Feb; 31(2):128-30. PubMed ID: 19194199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Hoang-Xuan K
    Bull Acad Natl Med; 2015 Nov; 199(8-9):1331. PubMed ID: 29874422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.